China’s Clover raises $230 million, plans vaccines for COVID-19 variants

China’s Clover Biopharmaceuticals, a developer of coronavirus vaccines, has raised $230 million from investors, including Singapore’s state investment firm Temasek Holdings, it said on Tuesday, as it …
( read original story …)